AstralBio and iBio, Inc. collaborated, leading to the development of multiple novel engineered antibody agonists.
1 report, 0 independent
Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AstralBio and iBio, Inc. collaborated, leading to the development of multiple novel engineered antibody agonists.
Coverage
Newest first; wire copies grouped- Unknown outlet